Using Garmin Vivosmart to track physical activity in children with Type 1 Diabetes
Garmin PACT (Physical Activity Tracking)
This study tests if using a Garmin Vivosmart fitness tracker can help kids and young adults with Type 1 Diabetes be more active and manage their diabetes better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 8 Years to 21 Years |
| Sex | All |
| Sponsor | Children's Mercy Hospital Kansas City Academic / other |
| Locations | 1 site (Kansas City, Missouri) |
| Trial ID | NCT05992350 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of the Garmin Vivosmart fitness tracker in increasing physical activity levels and improving diabetes management in children and youth aged 8 to 21 with Type 1 Diabetes. Participants will wear the device for one year and complete surveys at the beginning, middle, and end of the study to assess their diabetes status and physical activity. The study also involves parents of younger participants completing similar surveys to provide additional insights into diabetes management.
Who should consider this trial
Good fit: Ideal candidates are children and youth aged 8-21 years diagnosed with Type 1 Diabetes for more than six months.
Not a fit: Patients who are not diagnosed with Type 1 Diabetes or those unwilling to wear the device for the required duration may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance physical activity levels and diabetes management in children with Type 1 Diabetes.
How similar studies have performed: While the use of wearable technology in diabetes management is gaining traction, this specific approach using the Garmin Vivosmart is relatively novel and has not been extensively tested in similar studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants aged 8-21 years of age and/or parent of participant aged 8-17 years of age * Participants diagnosed with T1D greater than 6 months ago * Participants must be patients at the Children's Mercy Kansas City network Exclusion Criteria: * Participants who do not meet age criteria above * Participants who do not have T1D * Participants who are unwilling to wear the device for at least 6 months
Where this trial is running
Kansas City, Missouri
- Children's Mercy — Kansas City, Missouri, United States (Recruiting)
Study contacts
- Principal investigator: Mark Clements, MD — Children's Mercy
- Study coordinator: Priscilla Connell, MPH
- Email: pcconnell@cmh.edu
- Phone: 816-601-4543
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.